6-keto-pgf1alpha

6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 3430 references associated with 6-keto-pgf1alpha in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 6-keto-pgf1alpha

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 6-keto-pgf1alpha

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Diseases D008171 37 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Per page 10 20 50 100 | Total 60

PubChem Associated disorders and diseases

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with 6-keto-pgf1alpha

Download all related citations
Per page 10 20 50 100 | Total 2741
Authors Title Published Journal PubMed Link
Obilade OA et al. Prostacyclin, thromboxane and glomerular filtration rate are abnormal in sickle cell pregnancy. 2017 PLoS ONE pmid:28880908
Xie P et al. Antithrombotic Effect and Mechanism of Radix Paeoniae Rubra. 2017 Biomed Res Int pmid:28299338
Pallio G et al. Use of a balanced dual cyclooxygenase-1/2 and 5-lypoxygenase inhibitor in experimental colitis. 2016 Eur. J. Pharmacol. pmid:27450484
Khan F et al. Pretreatment of cultured preadipocytes with arachidonic acid during the differentiation phase without a cAMP-elevating agent enhances fat storage after the maturation phase. 2016 Prostaglandins Other Lipid Mediat. pmid:26928048
Brosnihan KB et al. Local intra-uterine Ang-(1-7) infusion attenuates PGE2 and 6-keto PGF1α in decidualized uterus of pseudopregnant rats. 2016 Reprod. Biol. Endocrinol. pmid:27756404
Ho HL et al. Role of cyclooxygenase isoforms in encephalopathy of cirrhotic rats. 2016 J Chin Med Assoc pmid:27580512
Ma N et al. Evaluation on antithrombotic effect of aspirin eugenol ester from the view of platelet aggregation, hemorheology, TXB2/6-keto-PGF1α and blood biochemistry in rat model. 2016 BMC Vet. Res. pmid:27296110
Sugita R et al. A novel selective prostaglandin E2 synthesis inhibitor relieves pyrexia and arthritis in Guinea pigs inflammatory models. 2016 J. Pharmacol. Sci. pmid:26906248
Yan H et al. Seawater Immersion Aggravates Burn Injury Causing Severe Blood Coagulation Dysfunction. 2016 Biomed Res Int pmid:26885523
Sanchez RA et al. Pro Atrial Natriuretic Peptide (1-30) and 6-keto PGF1α Activity Affects Na(+) Homeostasis in Non-modulating Hypertension. 2015 Curr Hypertens Rev pmid:26028240